Navigation Links
New Studies Support Dermatologists' Recommendation: Self-Exams, Screenings Vital for Detecting Skin Cancer
Date:5/5/2008

SCHAUMBURG, Ill., May 5 /PRNewswire/ -- When detected early, most skin cancers can be successfully treated. In fact, melanoma, the most serious form of skin cancer, is highly curable when found and treated early. The five-year survival rate for people whose melanoma is detected and treated before it spreads to the lymph nodes is 99 percent. However, dermatologists caution that finding skin cancer in its earliest stages requires a commitment by individuals to perform regular skin self-examinations and to report any suspicious moles or unusual changes to their dermatologist immediately.

Now, new research shows that involving a partner in the self-examination process, particularly one with whom an individual has a good relationship, makes it more likely that self screening will happen and can improve the early detection of skin cancer which could lead to a better prognosis.

"The American Academy of Dermatology (Academy) has been a leading advocate of the importance of skin self-exams and free community-based screening events as a means to detecting skin cancer," said dermatologist C. William Hanke, MD, MPH, FAAD, president of the Academy. "Since its inception in 1985, the Academy's National Melanoma/Skin Cancer Screening Program has screened more than 1.8 million people across the country and detected more than 180,170 suspicious lesions. This new research confirms what dermatologists have known for years -- early detection of skin cancer through self-exams and free screenings by dermatologists, whether conducted in the community or in the workplace, can save lives."

Partner-Assisted Skin Self-Exams

In an article entitled "Examination of mediating variables in a partner assistance intervention designed to increase performance of skin self-examination," published in the March 2007 issue of the Journal of the American Academy of Dermatology, dermatologist June K. Robinson, MD, FAAD, professor of clinical dermatology at Northwestern Univ
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Gene Studies of Male-Female Differences Often Flawed
2. Two studies published in the Lancet
3. Study of Studies Finds No Risk to Children From Phthalates in Toys
4. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
5. Studies Prove Exercise Can Heal the Body Mind and Soul
6. Studies Shed New Light on Breast Cancer, Treatment
7. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
...MMR shots found itself in the eye of a storm in th... to autism in some cases.// Recent statistics enab...firmed their faith in the MMR shots, and are well ... from Measles, Mumps and Rubella. The number of M...
...Researchers at the George Institute for Internatio...hat heart disease is the number one killer in rura...a large survey in Andhra Pradesh. The findings of ...rnal of Epidemiology this week. The report said In...
...New study by prescription manager Medco Health sol...ke ADHD medicine end up taking the drugs themselve...000 children and their parents last year. The stu...g ADHD medicine, it is more likely that the other ...
...Tonsillitis, a throat disease common among kids, c...apy, says a new study. // Children aged three-sev...lly caused by viruses, though certain bacteria are...illitis. Michael Pichichero and colleagues at the...
Other Medicine News:Health News:Chronic Diseases Rampant In Rural India 2
(Date:8/18/2008)... JERUSALEM, Israel, August 18 /PRNewswire-FirstCal...) ( http://www.oramed.com ), a developer,of oral d..., entitled "Open,Label Study to Assess the Safety,...f Five Oral Insulin Formulations in Healthy,Subjec...ing 44th Annual,Meeting of the European Associatio...
(Date:8/18/2008)...Industry Leader with Strong Clinical Research Rela...owth Organizations to Lead Commercialization, SAN...- NewCardio, Inc.,(OTC Bulletin Board: NWCI) a ca...nced that Vincent W. Renz has joined NewCardio as ... commercialization effort, to include,business dev...
(Date:8/18/2008)... BETHESDA, Md., Aug. 18 /- ...al company developing novel, proprietary,antibodie...toimmune,diseases, will host a webcast and confere... 10:00 a.m. Eastern Time (4:00 p.m. Central Europe...e published in the Journal,SCIENCE on August 15, 2...
(Date:8/15/2008)... AUDUBON, Pa., Aug. 15 /- Globus Medi...nt manufacturer in the world, today announced,that...en implanted under an,Investigational Device Exemp...ald Johnson II and Dr. Rhett Murray., The FLEXUS(...tween two,spinous processes with minimal disruptio...
Breaking Medicine Technology:Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Vincent W. Renz Joins NewCardio as President 2Vincent W. Renz Joins NewCardio as President 3Vincent W. Renz Joins NewCardio as President 4Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2291 1Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2291 2Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2291 3Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration Resistant Prostate Cancer Patients at 44th ASCO Annual Meeting 2291 4Drinking polyphenol rich Concord grape juice may improve memory in older adults 20857 1Drinking polyphenol rich Concord grape juice may improve memory in older adults 20857 2Louisiana May Mandate Fluoridation Despite Evidence of Harm 20853 1Louisiana May Mandate Fluoridation Despite Evidence of Harm 20853 2Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming WUWHS Conference 20849 1Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming WUWHS Conference 20849 2Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming WUWHS Conference 20849 3Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY 28TM 29 Wound 26 Burn Dressings at Upcoming WUWHS Conference 20849 4
..., Calif., May 02, 2007 /PRNewswire/ -- Ceregene, I...hase 1 trial of,CERE-110, a gene therapy product d...he treatment of Alzheimer,s disease. After one,yea...ho received,CERE-110 in the trial indicate that a ...rated, and an interim analysis suggested that,the ...
...Y, Mo.--(BUSINESS WIRE)--May 4, 2007 - New data ha...sclerosis (RRMS),patients treated with COPAXONE(R)...munosuppression with mitoxantrone experienced a,90...MRI)-monitored,disease activity compared to their ...d were sustained throughout the 24-month study,per...
Other Medicine Technology:Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 2Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 3Ceregene Presents Interim Phase 1 Clinical Data of CERE-110 for the,Treatment of Alzheimer's Disease 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 2Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 3Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 4Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 5Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 6Copaxone Treatment over Two Years after Short Term Induction with,Mitoxantrone Provided Sustained Benefits to Active,Relapsing-Remitting Multiple Sclerosis Patients 7
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: